Better epitope discovery, precision immune engineering, and accelerated vaccine design using immunoinformatics tools

AS De Groot, L Moise, F Terry, AH Gutierrez… - Frontiers in …, 2020 - frontiersin.org
Computational vaccinology includes epitope mapping, antigen selection, and immunogen
design using computational tools. Tools that facilitate the in silico prediction of immune …

Harnessing the power of T cells: the promising hope for a universal influenza vaccine

EB Clemens, C Van de Sandt, SS Wong, LM Wakim… - Vaccines, 2018 - mdpi.com
Next-generation vaccines that utilize T cells could potentially overcome the limitations of
current influenza vaccines that rely on antibodies to provide narrow subtype-specific …

Designing a multi-epitope vaccine to provoke the robust immune response against influenza A H7N9

H Tarrahimofrad, S Rahimnahal, J Zamani… - Scientific Reports, 2021 - nature.com
A new strain of Influenza A Virus (IAV), so-called" H7N9 Avian Influenza", is the first strain of
this virus in which a human is infected by transmitting the N9 of influenza virus. Although …

Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy

G Richard, MF Princiotta, D Bridon… - Expert Review of …, 2022 - Taylor & Francis
Introduction The field of cancer therapy has undergone a major transformation in less than a
decade due to the introduction of checkpoint inhibitors, the advent of next generation …

iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines

L Moise, A Gutierrez, F Kibria, R Martin… - Human vaccines & …, 2015 - Taylor & Francis
Computational vaccine design, also known as computational vaccinology, encompasses
epitope mapping, antigen selection and immunogen design using computational tools. The …

[HTML][HTML] Immunogenicity risk assessment of synthetic peptide drugs and their impurities

AS De Groot, BJ Roberts, A Mattei, S Lelias… - Drug Discovery …, 2023 - Elsevier
Peptide drugs play an important part in medicine owing to their many therapeutic
applications. Of the 80 peptide drugs approved for use in humans, at least five are now off …

Identification of immunodominant T cell epitopes induced by natural Zika virus infection

CS Eickhoff, KA Meza, FE Terry, CG Colbert… - Frontiers in …, 2023 - frontiersin.org
Zika virus (ZIKV) is a flavivirus primarily transmitted by Aedes species mosquitoes, first
discovered in Africa in 1947, that disseminated through Southeast Asia and the Pacific …

Neoadjuvant personalized cancer vaccines: the final frontier?

G Richard, N Ruggiero, GD Steinberg… - Expert Review of …, 2024 - Taylor & Francis
Introduction Clinical trials of personalized cancer vaccines have shown that on-demand
therapies that are manufactured for each patient, result in activated T cell responses against …

In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies

AE Mattei, AH Gutierrez, S Seshadri, J Tivin, M Ardito… - Mabs, 2024 - Taylor & Francis
In silico immunogenicity risk assessment has been an important step in the development
path for many biologic therapeutics, including monoclonal antibodies. Even if the source of a …

Highly conserved influenza T cell epitopes induce broadly protective immunity

CS Eickhoff, FE Terry, L Peng, KA Meza, IG Sakala… - Vaccine, 2019 - Elsevier
Influenza world-wide causes significant morbidity and mortality annually, and more severe
pandemics when novel strains evolve to which humans are immunologically naïve. Because …